Paclitaxel bei Ovarialkarzinom besser

  • r -- Piccart MJ, Bertelsen K, James K et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst 2000 (3. Mai); 92: 699-708 [Link]